These findings align with a previously reported case in an Ecuadorian patient with PTC, in which in silico analyses of tumor tissue identified potentially pathogenic variants in KIT (p.Leu678Phe) and BRAF (V600E). The gene discussed is KIT; the disease is neoplasm.